首页 | 本学科首页   官方微博 | 高级检索  
检索        

降纤酶和东菱克栓酶治疗脑梗死的疗效观察
引用本文:朱佩华,李东辉.降纤酶和东菱克栓酶治疗脑梗死的疗效观察[J].现代中西医结合杂志,2001,10(5):393-394.
作者姓名:朱佩华  李东辉
作者单位:江苏省淮阴市第一人民医院分院神经科,223002
摘    要:目的 :观察降纤酶和东菱克栓酶治疗脑梗死的疗效。方法 :选用脑梗死患者 85例 ,其中应用降纤酶治疗 5 2例 ,东菱克栓酶治疗 3 3例。结果 :两组疗效分别为 90 .5 %和 93 .9% ,两组疗效相比无统计学上的显著性意义。结论 :两组疗效相当 ,且疗效与病程无相关性 ,故对病程较长者亦有一定疗效。

关 键 词:降纤酶  东菱克栓酶  脑梗死

Clinical effect observation of defibrase and DF-521 in treatment of cerebral infarction
Zhu Peihua,Li Donghui.Clinical effect observation of defibrase and DF-521 in treatment of cerebral infarction[J].Modern Journal of Integrated Chinese Traditional and Western Medicine,2001,10(5):393-394.
Authors:Zhu Peihua  Li Donghui
Institution:Zhu Peihua,Li Donghui Department of Neurology,the First People's Hospital of Huaiyin City,Jiangsu Province 223002
Abstract:Objective:It is to observe the clinical effect of defibrase and DF-521 in treatment of cerebral infarction.Methods: 85 cases with cerebral infarction were selected. 52 cases were treated with defibrase, 33 cases were treated with DF- 521.Results: The clinical effects in the two groups were 90.5% and 93.9% respectively. There were no statistical significant differences between the two groups. Conclusion:The clinical effects in the two groups were equal. There was no relationship between the effect and the disease course. So they could be used in patients with length disease course.
Keywords:defibrase    DF-521    cerebral infarction
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号